| Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry S Tyagi, DK Nauriyal, R Gulati Review of Managerial Science 12 (1), 167-202, 2018 | 50 | 2018 |
| Innovations in Indian drug and pharmaceutical industry: have they impacted exports? S Tyagi, V Mahajan, DK Nauriyal NISCAIR-CSIR, India, 2014 | 47 | 2014 |
| Firm level profitability determinants in Indian drugs and pharmaceutical industry S Tyagi, DK Nauriyal International Journal of Pharmaceutical and Healthcare Marketing, 2017 | 44 | 2017 |
| Profitability determinants in Indian drugs and pharmaceutical industry: an analysis of pre and post TRIPS period S TYAGI, DK NAURIYAL Eurasian Journal of Business and Economics 9 (17), 1-21, 2016 | 21 | 2016 |
| What Determines Profitability in the Indian Automobile Industry? S Tyagi, V Mahajan The Indian Economic Journal, 00194662211063574, 2021 | 6 | 2021 |
| Do innovative activities matter to Indian drug and pharmaceutical firms? An application to export performance S Tyagi, DK Nauriyal Journal of Generic Medicines 13 (4), 193-205, 2017 | 6 | 2017 |
| Firm-Level Determinants of Industrial R&D: Empirical Evidence from the Indian R&D Intensive Industries S Tyagi International Journal of Business and Economics 7 (1), 202-211, 2022 | | 2022 |
D.K. NauriyalDept. of Humanities & Social Scs., Indian Institute of Technology Roorkee, RoorkeeVerified email at iitr.ac.in
